Table 1.
Changes in the standard of care with the gradual implementation of an enhanced recovery after surgery (ERAS) protocol
| Standard of care at commencement of study | Changes to care by quartile |
|---|---|
| Preoperative care | No changes |
| Admission on day of surgery | |
| Oral carbohydrate loading | |
| No bowel preparation or routine use of premedication | |
| Prophylactic antibiotics on induction and at closure if the duration of surgery exceeds 180 min | |
| Intraoperative care | Quartile 1 |
| Anaesthesia with volatile anaesthetic, short-acting opioids and anti-emetics | From hepatic resection 14: switch from epidural analgesia to intrathecal morphine because of inability to provide an appropriate post-epidural care package18 |
| Intravenous fluids: titrated against central venous pressure (central venous pressure targeted at <5 cmH2O intraoperatively, then 8 cmH2O in the early postoperative period) | From hepatic resection 27: introduction of bolus delivery (intermittent) wound catheters with 40 ml 0.2% ropivacaine every 6 h for 3 days with a 3-mg/kg loading dose at the time of closure |
| Intraoperative hypothermia was minimized by use of upper and lower body warming devices | Quartile 3 |
| All resections were performed by open surgery using transverse incisions | From hepatic resection 79: commercial continuous delivery system of 0.2% ropivacaine |
| Not used routinely: drains, nasogastric tubes | |
| Postoperative care | Quartile 1 |
| Deep vein thrombosis prophylaxis (20–40 mg enoxaparin subcutaneously from the evening of surgery) | From hepatic resection 8: routine use of NSAIDs with omeprazole cover at 24 h postoperatively |
| Analgesia: paracetamol 1 g q.i.d. | |
| Opioid-based patient-controlled analgesia | |
| Anti-emetics as required | |
| Not used routinely: laxatives, diuretics, immunonutrition, gabapentin19 | |
| Eat and drink as tolerated without restriction from day 0 | |
| Early mobilization | |
| Urinary catheter removed at day 1 | |
NSAIDs, non-steroidal anti-inflammatory drugs.